A novel compound heterozygous missense mutation in ASNS broadens the spectrum of asparagine synthetase deficiency
Open Access
- 7 April 2020
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (6) , e1235
Abstract
Background: Asparagine synthetase deficiency (ASNSD) is a rare pediatric congenital disorder that clinically manifests into severe progressive microcephaly, global developmental delay, spastic quadriplegia, and refractory seizures. ASNSD is caused by inheritable autosomal recessive mutations in the asparagine synthetase (ASNS) gene.Methods: We performed whole‐exome sequencing using the patient's peripheral blood, and newly discovered mutations were subsequently verified in the patient's parents via Sanger sequencing. Software‐based bioinformatics analyses (protein sequence conservation analysis, prediction of protein phosphorylation sites, protein structure modeling, and protein stability prediction) were performed to investigate and deduce their downstream effects.Results: In this article, we summarized all the previously reported cases of ASNSD and that of a Chinese girl who was clinically diagnosed with ASNSD, which was later confirmed via genetic testing. Whole‐exome sequencing revealed two compound heterozygous missense mutations within the ASNS (c.368T > C, p.F123S and c.1649G > A, p.R550H). The origin of the two mutations was also verified in the patient's parents via Sanger sequencing. The mutation c.368T > C (p.F123S) was discovered and confirmed to be novel and previously unreported. Using software‐based bioinformatics analyses, we deduced that the two mutation sites are highly conserved across a wide range of species, with the ability to alter different phosphorylation sites and destabilize the ASNS protein structure. The newly identified p.F123S mutation was predicted to be the most significantly destabilizing and detrimental mutation to the ASNS protein structure, compared to all other previously reported mutations.Conclusion: Evidently, the presence of these compound heterozygous mutations could lead to severe clinical phenotypes and serve as a potential indicator for considerably higher risk with less optimistic prognosis in ASNSD patients.Keywords
Funding Information
- National Natural Science Foundation of China (81571237)
This publication has 30 references indexed in Scilit:
- Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delayMetabolic Brain Disease, 2014
- DUET: a server for predicting effects of mutations on protein stability using an integrated computational approachNucleic Acids Research, 2014
- Deficiency of Asparagine Synthetase Causes Congenital Microcephaly and a Progressive Form of EncephalopathyNeuron, 2013
- An update on serine deficiency disordersJournal of Inherited Metabolic Disease, 2013
- Integrative genomics viewerNature Biotechnology, 2011
- Amino Acid Cerebrospinal Fluid/Plasma Ratios in Children: Influence of Age, Gender, and Antiepileptic MedicationPediatrics, 2008
- Asparagine Synthetase ChemotherapyAnnual Review of Biochemistry, 2006
- Prediction of protein stability changes for single‐site mutations using support vector machinesProteins: Structure, Function, and Bioinformatics, 2005
- Prediction of post‐translational glycosylation and phosphorylation of proteins from the amino acid sequenceProteomics, 2004
- Sequence and structure-based prediction of eukaryotic protein phosphorylation sitesJournal of Molecular Biology, 1999